• Streptococcus pyogenes, Group A Antibody (Streptozyme), Titer
  • FLG (filaggrin) Gene Mutation Analysis
  • PPOX Gene Mutation Analysis, Tissue
  • Amoebic Serology
  • Giardia lamblia Antibody, IgG, IgA, IgM , ELISA
  • Alkaline Phosphatase Isoenzymes
  • Beta-2 Microglobulin, Serum
  • B-Type Natriuretic Peptide (BNP)
  • Dengue Virus Antibody, IgM, Serum
  • Factor XIII (F13A1) V34L Genetic Variation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Medical Test

Turnaround Time
Access to Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants is restricted.